Teligent's Creditors Decry 'Skewed' Bankruptcy Financing
Unsecured creditors of generics pharmaceutical company Teligent Inc. objected Tuesday to the company's proposed bankruptcy financing, calling a proposed roll-up of $42.7 million in prepetition debt for two of its lenders "skewed"...To view the full article, register now.
Already a subscriber? Click here to view full article